Latest News and Press Releases

Total revenue of $12.2 million demonstrates the Company's solid momentum year over year and ongoing growth in the rapidly expanding bulk sales market.Entourage made a strong impact with new product...

TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning cannabis...

Total revenue of $16.4 million represents a 9% increase year-over-year and a 23% sequential increase from Q4 2023.Gross profit before fair value changes improved by 92% year-over-year, leading to a...

TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...

Gross profit before fair value changes reached $2.4 million, reflecting a 126% year-over-year increase.Company demonstrates financial gains with a 23% reduction in the cost of goods sold.SG&A...

TORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis...

Total revenue of $15.1 million in Q1 2023 represents a 24% sequential increase over Q4 2022.Net Revenue in medical accounted for $6.0 million, a 61% sequential increase over Q4 2022.Color Cannabis...

Company financials to be filed after market on May 29, 2023, and operational outlook to be provided during call, including milestones achieved. Company announces issuance of 1,423,057 common shares...

Record net medical revenue of $17.4 million for 2022, representing 16% growthEntourage secured a 5% share of total sales, ranking them in the fourth spot of national pre-roll sales in 2022Upsized...

TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...